Treatment Options and Self-Care for Tardive Dyskinesia (TD)

Tue Dec 03 2024 at 06:00 pm to 07:30 pm UTC-05:00

Online | Online

NAMI NYC Public Education Events
Publisher/HostNAMI NYC Public Education Events
Treatment Options and Self-Care for Tardive Dyskinesia (TD) Join NAMI-NYC and Teva Pharmaceuticals for an informative presentation on tardive dyskines
About this Event

Tuesday, December 3 from 6-7:30 PM (virtual)

Treatment Options and Self-Care for Tardive Dyskinesia (TD)

Join NAMI-NYC and Teva Pharmaceuticals virtually on Tuesday, December 3 from 6-7:30 PM, for an informative presentation on tardive dyskinesia (TD). Featuring guest speaker Stacy Finkbeiner, the U.S. Medical Director at Teva and a PhD level scientist.


We will discuss:

  • Causes and symptoms of tardive dyskinesia
  • How treatable TD symptoms can impact quality of life
  • Community-based programs and resources for people living with schizophrenia and their family members


Tardive dyskinesia (pronunciation) is a movement disorder associated with taking antipsychotic medications. These drugs are used to treat many mental health conditions including schizophrenia. The literal meaning of the term “tardive dyskinesia” (TD) is delayed movement disorder. “Tardive” refers to the lagging or late onset, while “dyskinesia” refers to the abnormal or involuntary movements.


TD causes stiff, jerky movements of your face and body that you can't control. You might blink your eyes, stick out your tongue, or wave your arms without meaning to do so.

Not everyone who takes an antipsychotic drug will get it. But if TD happens, it’s sometimes permanent.


This event will be held virtually on Teams.


Disclaimer: We cannot provide individual guidance on treatment options during this event. Please consult your provider.


About Our Guest Speaker:

Stacy is a Medical Director at Teva Pharmaceuticals and leads the company’s medical education and research efforts within the U.S. focused on the movement disorders of Tardive Dyskinesia and chorea associated with Huntington’s Disease. One of her key areas of focus is research to create a better understanding of how the irregular movements associated with Tardive Dyskinesia cause physical, psychological, social, and work impacts on individuals living with the condition. She is a PhD trained scientist and received her PhD in Microbiology from Washington University in St. Louis and went on to complete postdoctoral fellowships at Baylor School of Medicine in Houston and the University of Michigan in Ann Arbor. Prior to joining Teva, Stacy worked in the nonprofit sector to identify ways to increase and ensure access to medicines in low- and middle- income economies and led a variety of biotechnology & business/strategy consulting projects through a non-profit consulting organization she co-founded.


About Teva:

Teva Pharmaceutical Industries Ltd is a global pharmaceutical leader with a category-defying portfolio, harnessing our generics expertise and stepping up innovation to continue the momentum behind the discovery, delivery and expanded development of modern medicine. For over 120 years, Teva's commitment to bettering health has never wavered. Today, the company’s global network of capabilities enables its 37,000 employees across 60 markets to push the boundaries of scientific innovation and deliver quality medicines to help improve health outcomes of millions of patients every day.

Teva is steadily growing its portfolio of treatments for movement disorders and mental illnesses by developing options for treating tardive dyskinesia and schizophrenia. Tardive dyskinesia (TD) is mild to severe twitching, shaking, or jerking in the hands, feet, face, or torso. Involuntary blinking, tongue movements, and other uncontrollable movements can also be signs of TD. Embarrassment and avoiding going out in public may be emotional signs of TD impact. Involuntary movements of TD are real and can be treated. A healthcare provider can help.

Schizophrenia is a complex medical condition. Lifelong treatment with medicines and psychosocial therapy can help manage schizophrenia. Taking Medic*tion as prescribed may help people living with schizophrenia improve their symptoms and their quality of life. Medicine options include taking oral pills daily or receiving a long-acting treatment where Medic*tion stays in the body for a few weeks or months. Conversations with health care providers can help find the best treatment options.

To learn more about how Teva is all in for better health, visit www.tevapharm.com.

Event Venue

Online

Tickets

USD 0.00

Sharing is Caring:

More Events in Online

Young Writers: Long Term
Tue Dec 03 2024 Young Writers: Long Term

Online

Early Years FEEE  Spring Estimate Demo (Z1493)
Tue Dec 03 2024 at 06:15 pm Early Years FEEE Spring Estimate Demo (Z1493)

Online

The courts of poetry
Tue Dec 03 2024 at 06:30 pm The courts of poetry

Online

Online is Happening!

Never miss your favorite happenings again!

Explore Online Events